News
We previously covered Comcast (NASDAQ:CMCSA) in July 2023, discussing its excellent prospects through the year, thanks to the Mario movie’s blockbuster performance, further aided...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
News
This article was written by Follow Richard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the...
News
Follow Play Earnings CallPlay Earnings Call Silicon Laboratories Inc. (SLAB) Barclays 23rd Annual Global Technology Conference December 11, 2025 12:50 PM EST Company Participants...
News
A couple of years ago, I had a late-night hankering for some fast food, so I stopped by my local establishment. I generally avoided...
News
Investment thesis From the secular point of view, I am a big fan of the U.S. stock market because it has a stellar growth...
News
Millions of student loan borrowers have to make a payment this month for the first time in over three years. The moratorium on student...
News
Enphase Energy, Inc. (NASDAQ:ENPH) is down 61% year-to-date to maintain a drawdown that has seen the poster boy of the solar revolution shed around...
News
Company Description Academy Sports and Outdoors (NASDAQ:ASO) – Consumer Discretionary – Specialty retailer Founded in 1938, Academy Sports And Outdoors (“the company”) is a...
News
SolarEdge Technologies (NASDAQ:SEDG) has been a very strong performer since its public offering at $18 per share in 2015, but it has run into...
News
Introduction A new wave of covered call ETFs have swept unsuspecting income investors away with eye-popping distribution rates. The YieldMax TSLA Option Income Strategy...
News
Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting...
News
At a Glance United Therapeutics’ (NASDAQ:UTHR) Q2 performance underscores robust financials with a notable 27.7% YoY revenue increase, fueling investor optimism. On the clinical...
